CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response
暂无分享,去创建一个
J. Sampson | T. Keler | P. Fecci | Katherine A. Riccione | Li-Zhen He | L. Sanchez-Perez | Carter M. Suryadevara | P. Healy | E. Reap | Adam M. Swartz | P. Norberg | Kendra L Congdon | Qi-jing Li